Skip to main content

ENT Devices Market Size to Grow Higher by 2030

SkyQuest’s ENT Devices market report provides actionable insights for individuals interested in valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is produced and published concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections.

Westford, USA, June 15, 2023 (GLOBE NEWSWIRE) — The global ENT Devices market size is expected to reach USD 35.9 billion by 2030 and exhibit a CAGR of 5.74% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of ENT disorders, technological advancements in ENT devices, growing demand for minimally invasive surgeries, rising awareness and patient education regarding ENT disorders, increasing healthcare expenditure and insurance coverage, favorable reimbursement policies in some regions, growing adoption of hearing aids and implants for hearing loss, increasing geriatric population and associated ENT disorders are fueling the Market’s growth.

Government Subsidies and Incentives to Promote the Use of ENT Devices

At a global scale, the adoption of 3D printing technology for customized devices and implants, growing demand for portable and wireless devices, integration of artificial intelligence (AI) and machine learning (ML) in ENT devices, development of implantable hearing devices and cochlear implants with improved features, the introduction of advanced imaging technologies for more accurate diagnosis and treatment planning are promoting the market growth.

Several government initiatives, such as FDA guidance on ENT devices that help streamline the approval process, national deafness and other communication disorder programme manages hearing aid provision, medicare coverage for Cochlear Implants, and Japan’s initiative to promote hearing health are promoting innovations and funding research and development to improve the overall quality of care for the patients in ENT disorders.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/ent-devices-market

Hearing Aid Product Type Demand to Grow Substantially in the Forecast Period

Hearing aid product type dominated the global market owing to its increasing prevalence of hearing loss. It is also due to the technological advancements in hearing aids, such as the development of digital hearing aids that offer better sound quality and noise reduction, along with the increasing availability of rechargeable hearing aids. In addition, the World Health Organization estimates that approximately 466 million people globally have hearing loss, and this number is expected to increase to 630 million by 2030.

Nasal and Sinus is the Leading Application Segment

In terms of application, the nasal and sinus segment is the leading segment due to the increasing prevalence of chronic sinusitis and nasal disorders globally. In addition, chronic sinusitis affects a large population globally and is one of the most common reasons for ENT consultations. It is estimated that over 29 million people in the United States alone suffer from chronic sinusitis, and this number is expected to increase in the coming years.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/ent-devices-market

Asia-Pacific and North America are the leading Markets for Using Clean Energy

Region-wise, North America is one of the largest growing markets with the presence of advanced healthcare infrastructure, the increasing prevalence of ENT disorders, and the high adoption of technologically advanced ENT devices. The United States is a major contributor to the growth of the ENT devices market in North America due to the high incidence of ENT disorders in the country. For instance, it is estimated that over 20% of the adult population in the United States suffers from hearing loss, and this number is expected to increase in the coming years due to the aging population.

Browse in-depth TOC on ” ENT Devices Market ”

Pages – 251

Tables – 65

Figures – 75

ENT Devices Market Report Suggests:

  • Medtronic plc (NYSE: MDT) has acquired Intersect ENT to enhance its ear, nose, and throat (ENT) portfolio with innovative sinus products that improve post-operative outcomes and treat nasal polyps.
  • In terms of application, the Naval and sinus segment dominates due to the increasing prevalence of chronic sinusitis and nasal disorders globally.
  • In terms of type, the hearing Aid type segment is projected to gain more popularity due to the increasing prevalence of hearing loss
  • North America and Asia Pacific are leading markets and will continue to exhibit dominance in the global market mainly due developed health infrastructure

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/ent-devices-market

ENT Devices Market Segmentation:

The global ENT Devices market report is segmented based on Product type, application, and region.

By Product Type

  • Hearing Aids
  • Diagnostic Devices
  • Surgical Devices
  • Hearing Implants
  • Co2 Lasers
  • Others

By Application

  • Nasal and Sinus
  • Otology
  • Laryngology

By Region

  •  North America
  • U.S
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • RoE
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • RoLA
  • Middle-East and Africa
  • South Africa
  • GCC Countries
  • Rest of MEA

ENT Devices Market Major Company Profiles:

  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Olympus Corporation
  • Karl Storz SE & Co. KG
  • Cochlear Limited
  • Siemens Healthineers
  • GN Store Nord A/S
  • Sonova Holding AG
  • Starkey Hearing Technologies
  • Widex A/S
  • Smith & Nephew plc
  • William Demant Holding A/S
  • Natus Medical Incorporated
  • Rion Co. Ltd.
  • Intersect ENT, Inc.
  • Acclarent, Inc. (a subsidiary of Johnson & Johnson)
  • Lumenis Ltd.
  • Nihon Kohden Corporation
  • Atos Medical AB

Related Reports in SkyQuest’s Library:

Global Healthcare Additive Manufacturing Market

Global Sperm Bank Market

Global Aortic Aneurysm Market

Global 3D Printing Medical Devices Market

Global Peripheral Vascular Devices Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.